Fifth Third Bancorp grew its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 49.2% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 499,029 shares of the healthcare conglomerate's stock after purchasing an additional 164,523 shares during the quarter. Fifth Third Bancorp owned about 0.05% of UnitedHealth Group worth $135,032,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors also recently bought and sold shares of UNH. Sarver Vrooman Wealth Advisors bought a new position in shares of UnitedHealth Group in the 4th quarter valued at approximately $25,000. Beacon Financial Strategies CORP bought a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $26,000. Anfield Capital Management LLC boosted its holdings in shares of UnitedHealth Group by 220.0% during the 4th quarter. Anfield Capital Management LLC now owns 80 shares of the healthcare conglomerate's stock worth $26,000 after buying an additional 55 shares during the period. Joseph Group Capital Management bought a new position in UnitedHealth Group in the 4th quarter worth $27,000. Finally, Nalls Sherbakoff Group LLC bought a new stake in UnitedHealth Group during the fourth quarter valued at about $27,000. 87.86% of the stock is currently owned by institutional investors.
Insider Buying and Selling at UnitedHealth Group
In other news, CEO Patrick Hugh Conway sold 800 shares of the company's stock in a transaction that occurred on Thursday, April 23rd. The stock was sold at an average price of $355.00, for a total value of $284,000.00. Following the sale, the chief executive officer directly owned 17,805 shares in the company, valued at approximately $6,320,775. This represents a 4.30% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Corporate insiders own 0.28% of the company's stock.
UnitedHealth Group Stock Performance
Shares of UNH traded down $6.63 on Friday, reaching $425.05. 3,797,031 shares of the stock traded hands, compared to its average volume of 5,701,382. The firm has a market cap of $386.00 billion, a price-to-earnings ratio of 32.10, a P/E/G ratio of 1.71 and a beta of 0.62. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $434.30. The stock's 50-day moving average price is $399.40 and its 200-day moving average price is $338.88. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.80 and a quick ratio of 0.80.
UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 earnings per share for the quarter, topping analysts' consensus estimates of $6.76 by $0.47. The firm had revenue of $111.65 billion for the quarter, compared to the consensus estimate of $109.84 billion. UnitedHealth Group had a net margin of 2.68% and a return on equity of 14.65%. The business's revenue was up 2.0% compared to the same quarter last year. During the same quarter in the previous year, the company earned $7.20 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. Equities analysts forecast that UnitedHealth Group Incorporated will post 18.32 EPS for the current fiscal year.
UnitedHealth Group Increases Dividend
The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 23rd. Shareholders of record on Monday, June 15th were paid a dividend of $2.32 per share. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.21. This represents a $9.28 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date was Monday, June 15th. UnitedHealth Group's dividend payout ratio is 70.09%.
More UnitedHealth Group News
Here are the key news stories impacting UnitedHealth Group this week:
- Positive Sentiment: Royal Bank of Canada raised its price target on UnitedHealth Group to $463 from $400 and kept an outperform rating, signaling continued upside potential ahead of earnings. Benzinga
- Positive Sentiment: UnitedHealthcare launched a Lifestyle Spending Account benefit through UHC Store, which could make UNH more attractive to employers by adding flexible wellness benefits and simplifying administration. Article
- Positive Sentiment: Several recent articles highlight bullish setup momentum into the company’s July 16 earnings report, with investors expecting earnings and guidance to remain important catalysts. Article
- Neutral Sentiment: UnitedHealth’s home health program HouseCall was reported to be associated with fewer inpatient stays and ER visits, which is a positive operational sign but not an immediate market-moving event. Article
- Neutral Sentiment: Commentary also noted that UnitedHealth has delivered strong cash returns to shareholders over time, but some analysts are questioning whether the stock is now fully valued after its sharp recovery. Article
- Negative Sentiment: The broader healthcare sector was one of the weakest parts of the market today, and UNH was specifically cited as a drag on the Dow, which can weigh on the stock even if company-specific news is favorable. Article
Analysts Set New Price Targets
A number of equities analysts have recently commented on UNH shares. Barclays lifted their price objective on UnitedHealth Group from $373.00 to $429.00 and gave the stock an "overweight" rating in a research note on Tuesday, May 26th. Jefferies Financial Group upped their price target on UnitedHealth Group from $340.00 to $373.00 and gave the stock a "buy" rating in a report on Monday, April 20th. Bank of America raised their price objective on shares of UnitedHealth Group from $450.00 to $475.00 and gave the stock a "buy" rating in a research note on Wednesday, June 24th. Erste Group Bank upgraded shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a research note on Monday, April 27th. Finally, Sanford C. Bernstein restated an "outperform" rating on shares of UnitedHealth Group in a report on Tuesday, June 23rd. One analyst has rated the stock with a Strong Buy rating, twenty-one have assigned a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $417.38.
Read Our Latest Report on UNH
About UnitedHealth Group
(
Free Report)
UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.
UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.
Featured Stories
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.